KEY vs SER · P/E 13, rev $7.51B vs rev $56.0K
KeyCorp (KEY) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
KeyCorp (KEY) is a banks - regional company listed on US.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
KEY currently screens at market cap $22.64B and trailing P/E 12.8. SER currently screens at market cap $29.7M.
Not investment advice. Open the KEY and SER stock pages for the full models.
Not investment advice.